[Paraneoplastic pemphigus in chronic lymphocytic leukemia].
BACKGROUND
Paraneoplastic pemphigus is an autoimmune bullous disease described by precise clinical, histological and immunological features presented by Anhalt in 1990. Prognosis is very severe and depends on the associated neoplasia and the gravity of the mucosal damage.


METHODS
Paraneoplastic pemphigus was diagnosed in a 62-year-old man with chronic lymphoid leukemia. The course was favorable up to one-year follow-up after general corticosteroid therapy.


CONCLUSIONS
This case illustrates that paraneoplastic pemphigus can be controlled by general corticosteroids and would suggest the severe prognosis may be improved.
Fournier
B
B
Service de Dermatologie, Hôpital Bichat, Paris.
Bouscarat
F
F
Le Bozec
P
P
Joly
P
P
Gardin
P
P
Grossin
M
M
Descamps
V
V
Crickx
B
B
Belaïch
S
S
D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007150:Immunohistochemistry; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010257:Paraneoplastic Syndromes; D010392:Pemphigus / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use
D005938:Glucocorticoids; D011241:Prednisone